Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

F. Michael Cutrer, David Schoenfeld, Volker Limmroth, Nariman Panahian, Michael A. Moskowitz

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The effects of an intravenously administered sumatriptan analogue were examined on c‐fos‐like immunoreactivity (c‐fos‐LI), a marker of neuronal activation, evoked within trigeminal nucleus caudalis (TNC) and other brain stem regions 2 h after intracisternal injection of the irritant, capsaicin (0.1 ml, 0.1 mm), in pentobarbitone‐anaesthetized Hartley guinea‐pigs. C‐fos‐LI was assessed in eighteen serial sections (50 μm) using a polyclonal antiserum. A weighted average, reflecting total expression within lamina I, IIo of TNC was obtained from three representative levels (i.e., at −0.225 mm, −2.475 mm and −6.975 mm.) Capsaicin caused significant labelling within lamina I, IIo, a region containing axonal terminations of small unmyelinated C‐fibres, as well as within the nucleus of the solitary tract, area postrema and medial reticular nucleus. A similar distribution of positive cells was reported previously after intracisternal injection of other chemical irritants such as autologous blood or carrageenin. Pretreatment with a conformationally restricted sumatriptan analogue (with some selectivity for 5‐HT1B and 5‐HT1D receptor subtypes) CP‐122,288, reduced the weighted average by approximately 50–60% (P<0.05) in lamina I, IIo at ≥ 100 pmol kg−1, i.v., but did not decrease cell number within area postrema, nucleus of the solitary tract or medial reticular nucleus. A similar pattern was reported previously following sumatriptan, dihydroergotamine or CP‐93,129 administration after noxious meningeal stimulation. We conclude that modifications at the amino‐ethyl side chain of sumatriptan dramatically enhance the suppression of c‐fos expression within TNC, a finding consistent with its remarkable potency against neurogenic plasma protein extravasation within dura mater. CP‐122,288 and related analogues may serve as an important prototype for drug development in migraine and related headaches. 1995 British Pharmacological Society

Original languageEnglish (US)
Pages (from-to)987-992
Number of pages6
JournalBritish Journal of Pharmacology
Volume114
Issue number5
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Trigeminal Nuclei
Sumatriptan
Capsaicin
Area Postrema
Solitary Nucleus
Irritants
Dihydroergotamine
Dura Mater
Injections
Carrageenan
Migraine Disorders
Brain Stem
Blood Proteins
Immune Sera
Cell Count
Pharmaceutical Preparations
Spinal Cord Dorsal Horn

Keywords

  • 5‐HT agonist
  • capsaicin
  • CP‐122,288
  • c‐fos expression
  • headache
  • intracisternal
  • migraine
  • sumatriptan analogue
  • trigeminovascular system

ASJC Scopus subject areas

  • Pharmacology

Cite this

Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. / Cutrer, F. Michael; Schoenfeld, David; Limmroth, Volker; Panahian, Nariman; Moskowitz, Michael A.

In: British Journal of Pharmacology, Vol. 114, No. 5, 1995, p. 987-992.

Research output: Contribution to journalArticle

Cutrer, F. Michael ; Schoenfeld, David ; Limmroth, Volker ; Panahian, Nariman ; Moskowitz, Michael A. / Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. In: British Journal of Pharmacology. 1995 ; Vol. 114, No. 5. pp. 987-992.
@article{b218bface8ab46d39750b005b5853ac2,
title = "Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin",
abstract = "The effects of an intravenously administered sumatriptan analogue were examined on c‐fos‐like immunoreactivity (c‐fos‐LI), a marker of neuronal activation, evoked within trigeminal nucleus caudalis (TNC) and other brain stem regions 2 h after intracisternal injection of the irritant, capsaicin (0.1 ml, 0.1 mm), in pentobarbitone‐anaesthetized Hartley guinea‐pigs. C‐fos‐LI was assessed in eighteen serial sections (50 μm) using a polyclonal antiserum. A weighted average, reflecting total expression within lamina I, IIo of TNC was obtained from three representative levels (i.e., at −0.225 mm, −2.475 mm and −6.975 mm.) Capsaicin caused significant labelling within lamina I, IIo, a region containing axonal terminations of small unmyelinated C‐fibres, as well as within the nucleus of the solitary tract, area postrema and medial reticular nucleus. A similar distribution of positive cells was reported previously after intracisternal injection of other chemical irritants such as autologous blood or carrageenin. Pretreatment with a conformationally restricted sumatriptan analogue (with some selectivity for 5‐HT1B and 5‐HT1D receptor subtypes) CP‐122,288, reduced the weighted average by approximately 50–60{\%} (P<0.05) in lamina I, IIo at ≥ 100 pmol kg−1, i.v., but did not decrease cell number within area postrema, nucleus of the solitary tract or medial reticular nucleus. A similar pattern was reported previously following sumatriptan, dihydroergotamine or CP‐93,129 administration after noxious meningeal stimulation. We conclude that modifications at the amino‐ethyl side chain of sumatriptan dramatically enhance the suppression of c‐fos expression within TNC, a finding consistent with its remarkable potency against neurogenic plasma protein extravasation within dura mater. CP‐122,288 and related analogues may serve as an important prototype for drug development in migraine and related headaches. 1995 British Pharmacological Society",
keywords = "5‐HT agonist, capsaicin, CP‐122,288, c‐fos expression, headache, intracisternal, migraine, sumatriptan analogue, trigeminovascular system",
author = "Cutrer, {F. Michael} and David Schoenfeld and Volker Limmroth and Nariman Panahian and Moskowitz, {Michael A.}",
year = "1995",
doi = "10.1111/j.1476-5381.1995.tb13302.x",
language = "English (US)",
volume = "114",
pages = "987--992",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Suppression by the sumatriptan analogue, CP‐122,288 of c‐fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

AU - Cutrer, F. Michael

AU - Schoenfeld, David

AU - Limmroth, Volker

AU - Panahian, Nariman

AU - Moskowitz, Michael A.

PY - 1995

Y1 - 1995

N2 - The effects of an intravenously administered sumatriptan analogue were examined on c‐fos‐like immunoreactivity (c‐fos‐LI), a marker of neuronal activation, evoked within trigeminal nucleus caudalis (TNC) and other brain stem regions 2 h after intracisternal injection of the irritant, capsaicin (0.1 ml, 0.1 mm), in pentobarbitone‐anaesthetized Hartley guinea‐pigs. C‐fos‐LI was assessed in eighteen serial sections (50 μm) using a polyclonal antiserum. A weighted average, reflecting total expression within lamina I, IIo of TNC was obtained from three representative levels (i.e., at −0.225 mm, −2.475 mm and −6.975 mm.) Capsaicin caused significant labelling within lamina I, IIo, a region containing axonal terminations of small unmyelinated C‐fibres, as well as within the nucleus of the solitary tract, area postrema and medial reticular nucleus. A similar distribution of positive cells was reported previously after intracisternal injection of other chemical irritants such as autologous blood or carrageenin. Pretreatment with a conformationally restricted sumatriptan analogue (with some selectivity for 5‐HT1B and 5‐HT1D receptor subtypes) CP‐122,288, reduced the weighted average by approximately 50–60% (P<0.05) in lamina I, IIo at ≥ 100 pmol kg−1, i.v., but did not decrease cell number within area postrema, nucleus of the solitary tract or medial reticular nucleus. A similar pattern was reported previously following sumatriptan, dihydroergotamine or CP‐93,129 administration after noxious meningeal stimulation. We conclude that modifications at the amino‐ethyl side chain of sumatriptan dramatically enhance the suppression of c‐fos expression within TNC, a finding consistent with its remarkable potency against neurogenic plasma protein extravasation within dura mater. CP‐122,288 and related analogues may serve as an important prototype for drug development in migraine and related headaches. 1995 British Pharmacological Society

AB - The effects of an intravenously administered sumatriptan analogue were examined on c‐fos‐like immunoreactivity (c‐fos‐LI), a marker of neuronal activation, evoked within trigeminal nucleus caudalis (TNC) and other brain stem regions 2 h after intracisternal injection of the irritant, capsaicin (0.1 ml, 0.1 mm), in pentobarbitone‐anaesthetized Hartley guinea‐pigs. C‐fos‐LI was assessed in eighteen serial sections (50 μm) using a polyclonal antiserum. A weighted average, reflecting total expression within lamina I, IIo of TNC was obtained from three representative levels (i.e., at −0.225 mm, −2.475 mm and −6.975 mm.) Capsaicin caused significant labelling within lamina I, IIo, a region containing axonal terminations of small unmyelinated C‐fibres, as well as within the nucleus of the solitary tract, area postrema and medial reticular nucleus. A similar distribution of positive cells was reported previously after intracisternal injection of other chemical irritants such as autologous blood or carrageenin. Pretreatment with a conformationally restricted sumatriptan analogue (with some selectivity for 5‐HT1B and 5‐HT1D receptor subtypes) CP‐122,288, reduced the weighted average by approximately 50–60% (P<0.05) in lamina I, IIo at ≥ 100 pmol kg−1, i.v., but did not decrease cell number within area postrema, nucleus of the solitary tract or medial reticular nucleus. A similar pattern was reported previously following sumatriptan, dihydroergotamine or CP‐93,129 administration after noxious meningeal stimulation. We conclude that modifications at the amino‐ethyl side chain of sumatriptan dramatically enhance the suppression of c‐fos expression within TNC, a finding consistent with its remarkable potency against neurogenic plasma protein extravasation within dura mater. CP‐122,288 and related analogues may serve as an important prototype for drug development in migraine and related headaches. 1995 British Pharmacological Society

KW - 5‐HT agonist

KW - capsaicin

KW - CP‐122,288

KW - c‐fos expression

KW - headache

KW - intracisternal

KW - migraine

KW - sumatriptan analogue

KW - trigeminovascular system

UR - http://www.scopus.com/inward/record.url?scp=0028934001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028934001&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.1995.tb13302.x

DO - 10.1111/j.1476-5381.1995.tb13302.x

M3 - Article

VL - 114

SP - 987

EP - 992

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 5

ER -